Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-02-01

Clinical Trial Update: Changes in Mitochondrial Uncoupling Protein 2 (UCP2) Messenger RNA(mRNA) in Type 2 Diabetes (T2DM) Patients

View source ↗

Summary

This clinical trial update reports changes in mitochondrial uncoupling protein 2 (UCP2) mRNA levels in patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Diabetes | Status: UNKNOWN